The Application of the Insulin to C-Peptide Molar Ratio in Primary Screening for Insulin Antibodies in Type 2 Diabetes Mellitus Patients: A Further Quantitative Study on the Relationship Between ICPR and Insulin Antibodies
April 2023
in “
Diabetes Metabolic Syndrome and Obesity
”
TLDR 2h-ICPR can help screen for insulin antibodies in type 2 diabetes patients.
The study investigates the relationship between the 2-hour Insulin to C-Peptide Molar Ratio (2h-ICPR) and insulin antibodies in patients with type 2 diabetes mellitus. It concludes that 2h-ICPR can serve as a preliminary screening indicator for insulin antibody testing in these patients, suggesting its potential utility in clinical settings for early detection and management of insulin antibodies.
